Search Results - "Bailén, Rebeca"

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma by Kwon, Mi, Iacoboni, Gloria, Reguera, Juan Luis, Corral, Lucía López, Morales, Rafael Hernani, Ortiz-Maldonado, Valentín, Guerreiro, Manuel, Caballero, Ana Carolina, Domínguez, María Luisa Guerra, Pina, Jose Maria Sanchez, Mussetti, Alberto, Sancho, Juan Manuel, Bastos-Oreiro, Mariana, Catala, Eva, Delgado, Javier, Henriquez, Hugo Luzardo, Sanz, Jaime, Calbacho, María, Bailén, Rebeca, Carpio, Cecilia, Ribera, Jose Maria, Sureda, Anna, Briones, Javier, Hernandez-Boluda, Juan Carlos, Cebrián, Nuria Martínez, Martin, Jose Luis Diez, Martín, Alejandro, Barba, Pere

“…Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are CD19-targeted chimeric antigen receptor (CAR) T cells approved for relapsed/refractory…”
Get full text

Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma by Iacoboni, Gloria, Villacampa, Guillermo, Martinez‐Cibrian, Nuria, Bailén, Rebeca, Lopez Corral, Lucia, Sanchez, Jose M., Guerreiro, Manuel, Caballero, Ana Carolina, Mussetti, Alberto, Sancho, Juan‐Manuel, Hernani, Rafael, Abrisqueta, Pau, Solano, Carlos, Sureda, Anna, Briones, Javier, Martin Garcia‐Sancho, Alejandro, Kwon, Mi, Reguera‐Ortega, Juan Luis, Barba, Pere

“…Tisagenlecleucel (tisa‐cel) is a second‐generation autologous CD19‐targeted chimeric antigen receptor (CAR) T‐cell therapy approved for relapsed/refractory…”
Get full text

Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility by Gómez-Centurión, Ignacio, Oarbeascoa, Gillen, García, María Carmen, López Fresneña, María Carmen, Martínez Carreño, María Josefa, Escudero Vilaplana, Vicente, González-Haba, Eva, Bailén, Rebeca, Dorado, Nieves, Juárez, Luis Miguel, Rodríguez Macías, Gabriela, Font López, Patricia, Encinas, Cristina, Bastos-Oreiro, Mariana, Anguita, Javier, Sanjurjo, María, Díez-Martin, José Luis, Kwon, Mi

“…Background “Hospital-at-home” (HAH) programs have been shown to optimize resource utilization, shorten hospitalization and prevent nosocomial infection…”
Get full text

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy by Iacoboni, Gloria, Navarro, Víctor, Martín-López, Ana África, Rejeski, Kai, Kwon, Mi, Jalowiec, Katarzyna Aleksandra, Amat, Paula, Reguera-Ortega, Juan Luis, Gallur, Laura, Blumenberg, Viktoria, Gutiérrez-Herrero, Sara, Roddie, Claire, Benzaquén, Ana, Delgado-Serrano, Javier, Sánchez-Salinas, Mario Andrés, Bailén, Rebeca, Carpio, Cecilia, López-Corral, Lucia, Hernani, Rafael, Bastos, Mariana, O'Reilly, Maeve, Martín-Martín, Lourdes, Subklewe, Marion, Barba, Pere

“…Approximately 30%-40% of patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) infused with CD19-targeted chimeric antigen receptor (CAR) T…”
Get full text

Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation by Bailén, Rebeca, Kwon, Mi, Pascual-Cascón, María Jesús, Ferrà, Christelle, Sanz, Jaime, Gallardo-Morillo, Anabel, García-Sola, Abel, Torrent, Anna, Jiménez-Lorenzo, María José, Piñana, José Luis, Montoro, Juan, Oarbeascoa, Gillen, Dorado, Nieves, Gómez-Centurión, Ignacio, Muñoz, Cristina, Martínez-Laperche, Carolina, Anguita, Javier, Buño, Ismael, Díez-Martín, José Luis

“…Post-transplant cyclophosphamide (PTCY) effectively prevents graft-versus-host disease after unmanipulated HLA-haploidentical HSCT. The use of PTCY in the…”
Get full text

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation by Muñiz, Paula, Andrés-Zayas, Cristina, Carbonell, Diego, Chicano, María, Bailén, Rebeca, Oarbeascoa, Gillen, Suárez-González, Julia, Gómez Centurión, Ignacio, Dorado, Nieves, Gallardo, David, Anguita, Javier, Kwon, Mi, Díez-Martín, Jose L., Martínez-Laperche, Carolina, Buño, Ismael

“…Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for patients with hematologic malignances. Haploidentical HSCT…”
Get full text

Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation by Muñiz, Paula, Martínez-García, María, Bailén, Rebeca, Chicano, María, Oarbeascoa, Gillen, Triviño, Juan Carlos, de la Iglesia-San Sebastian, Ismael, Fernández de Córdoba, Sara, Anguita, Javier, Kwon, Mi, Díez-Martín, José Luis, Olmos, Pablo M, Martínez-Laperche, Carolina, Buño, Ismael

“…Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for hematological malignancies, it can be associated…”
Get full text

Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies by Fox, Maria Laura, García-Cadenas, Irene, Navarro, Victor, Martínez, Ariadna Pérez, Kara, Meriem, Bazán, Irene Sánchez, Ferra Coll, Christelle, Bailén, Rebeca, Bento, Leyre, Parody, Rocío, Esquirol, Albert, Ortí, Guillermo, Mussetti, Alberto, Salamero, Olga, Martino, Rodrigo, González, Ana Pérez, Barba, Pere, Kwon, Mi, Solano, Carlos, Bosch, Francesc, Valcárcel, David

“…Despite novel cellular and immunomodulatory therapies, allogeneic hematopoietic stem cell transplantation (HSCT) remains a treatment option for lymphoid…”
Get full text

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy by Bailén, Rebeca, Alenda, Raquel, Herruzo-Delgado, Beatriz, Acosta-Fleitas, Cynthia, Vallés, Ana, Esquirol, Albert, Fonseca, Marta, Solán, Laura, Sánchez-Vadillo, Irene, Bautista, Guiomar, Bento, Leyre, López-Godino, Oriana, Pérez-Martínez, Ariadna, Torrent, Anna, Zanabili, Joud, Calbacho, María, Moreno, Miguel Ángel, Pascual-Cascón, María Jesús, Guerra-Domínguez, Luisa, Chinea, Anabelle, García-Cadenas, Irene, López-Corral, Lucía, Boix-Giner, Francisco, López Lorenzo, José Luis, Humala, Karem, Duarte, Rafael, Sampol, Antonia, Heras, Inmaculada, Vicario, José Luis, Balas, Antonio, Oarbeascoa, Gillen, Fernández-Caldas, Paula, Anguita, Javier, Kwon, Mi

“…Donor-specific antibodies (DSAs) are IgG allo-antibodies against mismatched donor HLA molecules and can cause graft failure (GF) in the setting of…”
Get full text

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant by Bailén, Rebeca, Vicario, José Luis, Solán, Laura, Sánchez-Vadillo, Irene, Herrera, Pilar, Calbacho, María, Alenda, Raquel, López-Lorenzo, José Luis, Humala, Karem, Chinea, Anabelle, Sánchez-Pina, José, Balas, Antonio, Moreno, Miguel Ángel, Arzuaga, Javier, Pradillo, Virginia, Dorado, Nieves, Oarbeascoa, Gillen, Anguita, Javier, Díez-Martín, José Luis, Kwon, Mi

“…Background Donor specific antibodies (DSAs) can be responsible for graft failure (GF) in the setting of mismatched hematopoietic stem cell transplantation…”
Get full text

Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application by Navarro-Bailón, Almudena, Carbonell, Diego, Escudero, Asunción, Chicano, María, Muñiz, Paula, Suárez-González, Julia, Bailén, Rebeca, Oarbeascoa, Gillen, Kwon, Mi, Díez-Martín, José Luis, Martínez-Laperche, Carolina, Buño, Ismael

“…Chimerism refers to the relative proportion of donor and recipient DNA after hematopoietic stem cell transplantation (HSCT) and its quantitative follow-up is…”
Get full text

Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders by Kwon, Mi, Bailén, Rebeca, Balsalobre, Pascual, Jurado, Manuel, Bermudez, Arancha, Badiola, Jon, Esquirol, Albert, Miralles, Pilar, López-Fernández, Elisa, Sanz, Jaime, Yañez, Lucrecia, Colorado, Mercedes, Piñana, José L, Dorado, Nieves, Solán, Laura, Martínez Laperche, Carolina, Buño, Ismael, Anguita, Javier, Serrano, David, Díez-Martin, José L

“…INTRODUCTION:Although a number of patients with HIV infection and hematological disease have successfully undergone allogeneic hematopoietic stem-cell…”
Get full text

Allogeneic CD34‐selected stem cell boost as salvage treatment of life‐threatening infection and severe cytopenias after CAR‐T cell therapy by Tena, Pablo Silva, Bailén, Rebeca, Oarbeascoa, Gillen, Gómez‐Centurión, Ignacio, Pérez‐Corral, Ana, Carbonell, Diego, Martínez‐Laperche, Carolina, Sancho, Milagros, Bastos‐Oreiro, Mariana, Conde‐Royo, Diego, Fernández‐Caldas, Paula, Muñoz, Cristina, Sabell, Santiago, Buño, Ismael, Anguita, Javier, Díez‐Martín, José Luis, Kwon, Mi

“…Background A variable incidence of profound cytopenia has been described in patients receiving chimeric antigen receptor T‐cell (CAR‐T) therapy for relapsed or…”
Get full text

Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide by Muñiz, Paula, Kwon, Mi, Carbonell, Diego, Chicano, María, Bailén, Rebeca, Oarbeascoa, Gillen, Suárez-González, Julia, Andrés-Zayas, Cristina, Menárguez, Javier, Dorado, Nieves, Gómez-Centurión, Ignacio, Anguita, Javier, Díez-Martín, José Luis, Martínez-Laperche, Carolina, Buño, Ismael

“…Haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) with high-dose cyclophosphamide (PTCy) has resulted in a low incidence of graft-vs.-host…”
Get full text

Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center by Bailén, Rebeca, Pérez‐Corral, Ana María, Pascual, Cristina, Kwon, Mi, Serrano, David, Gayoso, Jorge, Balsalobre, Pascual, Muñoz, Cristina, Díez‐Martín, José Luis, Anguita, Javier

“…Background Poor mobilization results are unexpected after G‐CSF‐induced peripheral blood stem cell collection in healthy donors. However, 2%‐5% of the donors…”
Get full text

Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel by Martín‐Rojas, Reyes Maria, Gómez‐Centurión, Ignacio, Bailén, Rebeca, Bastos, Mariana, Diaz‐Crespo, Francisco, Carbonell, Diego, Correa‐Rocha, Rafael, Pion, Marjorie, Muñoz, Cristina, Sancho, Milagros, Gómez Fernández, Isabel, Oarbeascoa, Gillen, Pérez‐Corral, Ana, Martínez‐Laperche, Carolina, Anguita, Javier, Buño, Ismael, Menárguez, Javier, Díez‐Martín, Jose Luis, Kwon, Mi

“…Chimeric antigen receptor (CAR) T cell–related HLH/MAS is an unusual manifestation of severe cytokine release syndrome (CRS) with poor prognosis and a…”
Get full text

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms by Vallejo, Miren, Muñiz, Paula, Kwon, Mi, Solán, Laura, Bailén, Rebeca, Carbonell, Diego, Chicano, María, Suárez-González, Julia, Catalán, Pilar, Bellón, José María, Triviño, Juan Carlos, Dorado, Nieves, Gallardo, David, Díez-Martín, José Luis, Ramírez, Natalia, Martínez-Laperche, Carolina, Buño, Ismael

“…Despite advances in the understanding of the pathophysiology of cytomegalovirus (CMV) infection, it remains as one of the most common infectious complications…”
Get full text

Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation by Kwon, Mi, Bailén, Rebeca, Pascual-Cascón, María Jesús, Gallardo-Morillo, Ana Isabel, García Sola, Abel, Balsalobre, Pascual, Solán, Laura, Dorado, Nieves, Muñoz, Cristina, Serrano, David, Martínez-Laperche, Carolina, Buño, Ismael, Anguita, Javier, Díez-Martin, José Luis

“…Posttransplant cyclophosphamide (PTCy) effectively prevents graft-versus-host disease (GVHD) after HLA-haploidentical hematopoietic stem cell transplantation…”
Get full text

Efficacy and safety of bendamustine‐containing bridging therapy in R/R LBCL patients receiving CD19 CAR T‐cells by Iacoboni, Gloria, Sánchez‐Salinas, Mario A., Rejeski, Kai, Martín‐López, Ana Á., Kwon, Mi, Navarro, Víctor, Jalowiec, Katarzyna A., Hernani, Rafael, Reguera‐Ortega, Juan L., Gallur, Laura, Blumenberg, Viktoria, Herrero‐García, María, Roddie, Claire, Benzaquén, Ana, Delgado‐Serrano, Javier, Bailén, Rebeca, Carpio, Cecilia, Amat, Paula, López‐Corral, Lucia, Martín‐Martín, Lourdes, Bastos, Mariana, Subklewe, Marion, O'Reilly, Maeve, Barba, Pere

“…Bridging therapy (BT) after leukapheresis is required in most relapsed/refractory (R/R) large B‐cell lymphoma (LBCL) patients receiving chimeric antigen…”
Get full text

Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019 by Pérez-García, Felipe, Bailén, Rebeca, Torres-Macho, Juan, Fernández-Rodríguez, Amanda, Jiménez-Sousa, Maria Ángeles, Jiménez, Eva, Pérez-Butragueño, Mario, Cuadros-González, Juan, Cadiñanos, Julen, García-García, Irene, Jiménez-González, María, Ryan, Pablo, Resino, Salvador

“…Endothelial Activation and Stress Index (EASIX) predict death in patients undergoing allogeneic hematopoietic stem cell transplantation who develop endothelial…”
Get full text